BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu CY, Chu JY, Chiang JH, Yen HR, Hsu CH. Utilization and prescription patterns of traditional Chinese medicine for patients with hepatitis C in Taiwan: a population-based study. BMC Complement Altern Med 2016;16:397. [PMID: 27769222 DOI: 10.1186/s12906-016-1379-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Tsai FJ, Li TM, Cheng CF, Wu YC, Lai CH, Ho TJ, Liu X, Tsang H, Lin TH, Liao CC, Huang SM, Li JP, Lin JC, Lin CC, Liang WM, Lin YJ. Effects of Chinese herbal medicine on hyperlipidemia and the risk of cardiovascular disease in HIV-infected patients in Taiwan. J Ethnopharmacol 2018;219:71-80. [PMID: 29530610 DOI: 10.1016/j.jep.2018.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
2 Cho YM, Hui KK, Perng WT, Wang YH, Wei JC. Chinese herbal medicine might be associated with a lower rate of joint replacement in patients with osteoarthritis: A 12-year population-based matched cohort analysis. J Ethnopharmacol 2021;280:114419. [PMID: 34284084 DOI: 10.1016/j.jep.2021.114419] [Reference Citation Analysis]
3 Lu M, Livneh H, Chiu L, Lai N, Yeh C, Tsai T. A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data–based cohort study. Clin Rheumatol 2019;38:1393-400. [DOI: 10.1007/s10067-018-04425-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Li X, Li X, Lu J, Huang Y, Lv L, Luan Y, Liu R, Sun R. Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study. BMC Complement Altern Med 2017;17:219. [PMID: 28420359 DOI: 10.1186/s12906-017-1733-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
5 Tsai FJ, Cheng CF, Chen CJ, Lin CY, Wu YF, Li TM, Chuang PH, Wu YC, Lai CH, Liu X, Tsang H, Lin TH, Liao CC, Huang SM, Li JP, Lin JC, Lin CC, Liang WM, Lin YJ. Effects of Chinese herbal medicine therapy on survival and hepatic outcomes in patients with hepatitis C virus infection in Taiwan. Phytomedicine 2019;57:30-8. [PMID: 30668320 DOI: 10.1016/j.phymed.2018.09.237] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
6 Meng F, Ji Z, Song F, Bai T, Fan X, Wang D. Patients’ familiarity with, trust in and willingness to pay for traditional Chinese medicine in Chinese community health care centres. European Journal of Integrative Medicine 2020;36:101118. [DOI: 10.1016/j.eujim.2020.101118] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chang CP, Su YC, Lin MC, Huang ST. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study. Evid Based Complement Alternat Med 2019;2019:5319456. [PMID: 31871483 DOI: 10.1155/2019/5319456] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Tsai FJ, Yang PY, Chen CJ, Li JP, Li TM, Chiou JS, Cheng CF, Chuang PH, Lin TH, Liao CC, Huang SM, Ban B, Liang WM, Lin YJ. Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan. BMC Complement Med Ther 2020;20:221. [PMID: 32664975 DOI: 10.1186/s12906-020-03010-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Hsueh TP, Lin WL, Dalley JW, Tsai TH. The Pharmacological Effects and Pharmacokinetics of Active Compounds of Artemisia capillaris. Biomedicines 2021;9:1412. [PMID: 34680529 DOI: 10.3390/biomedicines9101412] [Reference Citation Analysis]
10 Tsai TY, Hung TH, Livneh H, Lin IH, Lu MC, Yeh CC. Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study. Oncotarget 2018;9:18214-23. [PMID: 29719600 DOI: 10.18632/oncotarget.24383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Hsueh TP, Tsai TH. Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone. BMC Complement Med Ther 2020;20:253. [PMID: 32799863 DOI: 10.1186/s12906-020-03042-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chen FP, Chang CM, Wu TP, Yang JL, Kung YY, Huang YH, Su CW, Lan KH, Chiang SC, Hwang SJ. Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover study. J Ethnopharmacol 2017;196:1-8. [PMID: 27965049 DOI: 10.1016/j.jep.2016.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Lin Y, Lee I, Huang W, Lin Y, Kuan F, Shu L, Cheng Y, Yang Y, Wu C. Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway. Journal of Ethnopharmacology 2017;209:305-16. [DOI: 10.1016/j.jep.2017.08.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]